Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

    Noecker R.

    Br J Ophthalmol. 2006 Nov;90(11):1336-7. No abstract available. PMID: 17057169 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

    Cantor LB, Hoop J, Morgan L, Wudunn D, Catoira Y; Bimatoprost-Travoprost Study Group.

    Br J Ophthalmol. 2006 Nov;90(11):1370-3. Epub 2006 Jul 6.PMID: 16825272 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparing bimatoprost and travoprost in black Americans.

    Noecker RJ, Earl ML, Mundorf TK, Silverstein SM, Phillips MP.

    Curr Med Res Opin. 2006 Nov;22(11):2175-80.PMID: 17076978 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

    Cantor LB, WuDunn D, Cortes A, Hoop J, Knotts S.

    Surv Ophthalmol. 2004 Mar;49 Suppl 1:S12-8.PMID: 15016557 [PubMed - indexed for MEDLINE]Related articles

    5.

    Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.

    Eisenberg DL, Toris CB, Camras CB.

    Surv Ophthalmol. 2002 Aug;47 Suppl 1:S105-15. Review.PMID: 12204706 [PubMed - indexed for MEDLINE]Related articles

    6.

    Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

    Li N, Chen XM, Zhou Y, Wei ML, Yao X.

    Clin Experiment Ophthalmol. 2006 Nov;34(8):755-64.PMID: 17073898 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.

    Noecker RJ, Walt JG.

    Am J Ophthalmol. 2006 Jan;141(1 Suppl):S15-21.PMID: 16389056 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension.

    Noecker RJ, Earl ML, Mundorf T, Peace J, Williams RD.

    Adv Ther. 2003 Mar-Apr;20(2):121-8.PMID: 12836812 [PubMed - indexed for MEDLINE]Related articles

    9.

    A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

    Parrish RK, Palmberg P, Sheu WP; XLT Study Group.

    Am J Ophthalmol. 2003 May;135(5):688-703.PMID: 12719078 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.

    Frenkel RE, Frenkel M, Toler A.

    BMC Ophthalmol. 2007 Sep 27;7:16.PMID: 17900371 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

    Robin AL.

    Am J Ophthalmol. 2003 Jun;135(6):921-2; author reply 922-3. No abstract available. PMID: 12788149 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.

    Koz OG, Ozsoy A, Yarangumeli A, Kose SK, Kural G.

    Acta Ophthalmol Scand. 2007 Dec;85(8):838-43. Epub 2007 Aug 2.PMID: 17680841 [PubMed - indexed for MEDLINE]Related articles

    13.

    A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study.

    Bernstein P.

    Am J Ophthalmol. 2004 Feb;137(2):387-8; author reply 388-9. No abstract available. PMID: 14962451 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

    Noecker RS, Dirks MS, Choplin N; Bimatoprost/Latanoprost Study Group.

    Am J Ophthalmol. 2004 Jan;137(1):210-1; author reply 211-2. No abstract available. PMID: 14700685 [PubMed - indexed for MEDLINE]Related articles

    15.

    Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

    Fellenbaum PS.

    Am J Ophthalmol. 2003 Aug;136(2):392; author reply 392-3. No abstract available. PMID: 12888081 [PubMed - indexed for MEDLINE]Related articles

    16.

    A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension.

    Robin AL.

    Eur J Ophthalmol. 2007 Jul-Aug;17(4):685-6; author reply 686-7. No abstract available. PMID: 17671954 [PubMed - indexed for MEDLINE]Related articles

    17.

    Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.

    Gagliuso DJ, Wang RF, Mittag TW, Podos SM.

    Arch Ophthalmol. 2004 Sep;122(9):1342-7.PMID: 15364714 [PubMed - indexed for MEDLINE]Related articles

    18.

    A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients.

    Alagoz G, Gürel K, Bayer A, Serin D, Celebi S, Kukner S.

    Ophthalmologica. 2008;222(2):88-95. Epub 2008 Feb 22.PMID: 18303228 [PubMed - indexed for MEDLINE]Related articles

    19.

    Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.

    Covert D, Robin AL.

    Curr Med Res Opin. 2006 May;22(5):971-6.PMID: 16709319 [PubMed - indexed for MEDLINE]Related articles

    20.

    Supplemental Content

    Find related data